Companies are looking to tackle aging and age-related diseases, and artificial intelligence could be a key technology to help surface potential solutions.
Is aging inevitable?
It’s a question that’s long perplexed scientists due to the complexities involved in understanding how we age.
And while major breakthroughs have been rare, we are starting to identify more cellular targets and mechanisms associated with aging and age-related diseases.
In particular, recent activities by aging-focused startups are creating buzz as they explore everything from stem cell therapies to blood transfusions. Among these, artificial intelligence has emerged as a key method to speed up this process and identify potential therapeutics.
In fact, a number of new biotech AI and AI SaaS platforms have cropped up in the drug discovery and formulation phase. Anti-aging research, among other related therapeutic areas, is benefiting from this trend.
Below, we dig into startups leveraging artificial intelligence to tackle aging.
(Check out our full report on the Future of Aging here)